3 enrolling by invitation. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 3 |
| Phase 1 | 1 | Enrolling by invitation 1 |
Follow Atorvastatin: new trials by email Literature Review of Atorvastatin trials Research Report on Atorvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet Atorvastatin 10mg, Modification of dietary fat composition - Epilepsy, Dyslipidemia | Phase 1 / Phase 2 | Enrolling by invitation | Johns Hopkins University | 22 | 2024-10-04 | 2026-10-19 |
| Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury Atorvastatin Calcium, Minocycline Hydrochloride, Candesartan Cilexetil - Traumatic Brain Injury | Phase 2 | Enrolling by invitation | University of California, San Francisco | 672 | 2024-08-01 | 2025-12-22 |
| Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease Atorvastatin 20 Mg Oral Tablet, Sodium Bicarbonate 600 Mg Oral Tablet - Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases | Phase 2 | Enrolling by invitation | Taipei Medical University Shuang Ho Hospital | 30 | 2023-05-01 | 2023-05-23 |
Brain Injuries, Traumatic (1) · Dyslipidemias (1) · Epilepsy (1) · Polycystic Kidney, Autosomal Dominant (1) · Renal Insufficiency, Chronic (1)
Johns Hopkins University (1) · Taipei Medical University Shuang Ho Hospital (1) · University of California, San Francisco (1)
United States (2) · Taiwan (1)
Geoffrey Manley, MD PhD (1) · Tanya J McDonald, MD, PhD (1)